Cartalax

Also known as: Ala-Glu-Asp-Gly, AEDG Peptide (4-mer), Cartilage Bioregulator

Muscle & Recovery

Research Only

Cartalax is a tetrapeptide bioregulator specifically developed for joint health, cartilage repair, and connective tissue regeneration. Part of the Khavinson peptide family, it targets chondrocytes (cartilage cells) and connective tissue fibroblasts to restore gene expression and promote repair. Used in protocols for joint degradation, arthritis, and sports injury recovery.

Regulatory & Approval Status

Not FDA Approved

There is no reliable clinical trial data available for Cartalax, and it is not approved by the FDA for any human use.

Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.

Unlock the complete research profile

Create your free CertifiedTide account to access full compound details, mechanisms, safety data, and research tools.